Previsioni

Non sono disponibili dati degli analisti per questa azienda.

Notizie Vai al feed delle notizie

Terveystalo Q3: revenue falls, margins and cash flow improve – stock plunges

Terveystalo reported a 5.2% decline in revenue for Q3 2025 to €280.4m, while adjusted EBIT remained almost stable at €26.8m and the adjusted EBIT margin rose to 9.5%. Earnings per share climbed 9.7% to €0.13 and operating cash flow increased 32% to €54.5m. Causes of the revenue decline include reduced outsourcing contracts, fewer occupational health services and lower sickness rates; the business in Sweden remains loss-making but is improving. Management confirmed the full-year guidance for adjusted EBIT of €155–165m; the share fell 8.25% to €9.23 after the release. » Altro su de.investing.com
Terveystalo share falls after 5% revenue decline in third quarter

Terveystalo reported a 5% revenue decline in Q3 2025 but maintained its adjusted EBIT guidance of €155–165m. The adjusted EBIT margin and operating cash flow improved, while the leverage ratio stood at 2.1. The stock reacted negatively, falling 8.15% in pre-market trading to $9.24. The company continues to invest in digital health services and expects growth in connected employees through 2026. » Altro su de.investing.com
Terveystalo reports record profitability in Q2 2025, shares fall despite strong EBIT

Terveystalo achieved record profitability in the second quarter of 2025 with EBIT of €36.7 million and a margin of 11.4%, but saw a slight decline in revenue compared to the previous year. The stock fell 7.35% in pre-market trading as investors expressed concerns about the revenue drop and weakness in the occupational health segment, despite strong profitability. The company maintains its full-year EBIT guidance and continues to focus on digital transformation and technological innovation. » Altro su de.investing.com

Dividendi storici Dividendi

Tutte le metriche sui dividendi Tutte le metriche

Nel 2026, Terveystalo ha già distribuito 0,32 € di dividendi. L'ultimo pagamento è avvenuto a aprile.

Dati finanziari dell'azienda

Nell'ultimo trimestre, Terveystalo ha registrato ricavi pari a 293,3 Mln € e un utile netto di 13,8 Mln €

(EUR)	giu 2026	YoY
Ricavi	293,3 Mln	8,77%
Utile lordo	172,4 Mln	10,72%
Utile netto	13,8 Mln	37,84%
EBITDA	47 Mln	17,40%

Dati fondamentali

Metrica	Valore
Capitalizzazione di mercato	979,58 Mln €
Numero di azioni	126,81 Mln
Massimo/minimo a 52 settimane	11,18 € - 7,72 €
Rendimento da dividendo	7,24%
Dividendi TTM	0,56 €
Beta	0,37
Rapporto P/E	14,17
Rapporto PEG	-0,59
Rapporto P/B	1,82
Rapporto P/S	0,80

Profilo aziendale

Terveystalo Oyj bietet betriebliche Gesundheitsdienste in Finnland an. Das Unternehmen bietet allgemeinmedizinische und fachärztliche Versorgung, Diagnostik, ambulante Chirurgie, zahnärztliche und andere angrenzende Dienstleistungen sowie Outsourcing-Dienstleistungen, Personaldienstleistungen, Kinderfürsorgedienstleistungen, Mundgesundheit, Labor, Bildgebung, Wohlbefinden, ambulante Chirurgie, Outsourcing im Gesundheitswesen, Personaldienstleistungen im Gesundheitswesen sowie Primär- und Spezialpflegedienstleistungen. Darüber hinaus bietet das Unternehmen eine Reihe von digitalen Gesundheitsdiensten und klinische Forschungsdienste an. Das Unternehmen bedient Privatpersonen, Unternehmen und Gemeinden, Versicherungsgesellschaften und Kunden des öffentlichen Sektors. Es betreibt 360 Kliniken, darunter 18 Krankenhäuser und 38 Zahnkliniken, sowie 73 Rela hierojat Massage-Therapie-Einheiten. Das Unternehmen wurde im Jahr 2001 gegründet und hat seinen Sitz in Helsinki, Finnland.